Skip to main content

Urticaria Topic Center

Research Summary
03/18/2026
Jessica Garlewicz
The findings of an analysis underscore the potential role of common viral infections as a trigger for AU and offer insight into changing disease patterns during the COVID-19 pandemic.
The findings of an analysis underscore the potential role of common viral infections as a trigger for AU and offer insight into changing disease patterns during the COVID-19 pandemic.
The findings of an analysis...
03/18/2026
Allergy & Immunology
RESEARCH INSIGHTS
03/13/2026
Thomas B. Casale, MD
Dr Casale provides an overview of his poster presentation at the American Academy of Allergy, Asthma, and Immunology annual meeting on whether age, gender, BMI, presence of angioedema, or IgE level affected how patients with chronic...
Dr Casale provides an overview of his poster presentation at the American Academy of Allergy, Asthma, and Immunology annual meeting on whether age, gender, BMI, presence of angioedema, or IgE level affected how patients with chronic...
Dr Casale provides an overview...
03/13/2026
Allergy & Immunology
Research Summary
01/29/2026
Rebecca Mashaw
New biologic agents and small-molecule therapies expanding options beyond traditional antihistamines and omalizumab.
New biologic agents and small-molecule therapies expanding options beyond traditional antihistamines and omalizumab.
New biologic agents and...
01/29/2026
Allergy & Immunology
Jonathan Bernstein, MD
Clinical Insights
01/20/2026
Jonathan A. Bernstein, MD
Allergist Jonathan Bernstein, MD, provided an in-depth review of diagnosing and treating chronic spontaneous urticaria.
Allergist Jonathan Bernstein, MD, provided an in-depth review of diagnosing and treating chronic spontaneous urticaria.
Allergist Jonathan Bernstein,...
01/20/2026
Allergy & Immunology
Clinical Review
01/16/2026
Rebecca Mashaw
A recent review suggests that chronic urticaria may be a cutaneous clue to systemic autoinflammatory disease.
A recent review suggests that chronic urticaria may be a cutaneous clue to systemic autoinflammatory disease.
A recent review suggests that...
01/16/2026
Allergy & Immunology
Quiz
01/05/2026
Riya Gandhi, MA
Assess longitudinal trends in chronic urticaria incidence across a five-year period, including during the pandemic and vaccination phases, in this data-driven quiz.
Assess longitudinal trends in chronic urticaria incidence across a five-year period, including during the pandemic and vaccination phases, in this data-driven quiz.
Assess longitudinal trends in...
01/05/2026
Allergy & Immunology
News
12/06/2025
Jessica Garlewicz
New evidence suggests that blastocystis infection may contribute to immune dysregulation in urticaria through alterations in the intestinal microbiota.
New evidence suggests that blastocystis infection may contribute to immune dysregulation in urticaria through alterations in the intestinal microbiota.
New evidence suggests that...
12/06/2025
Allergy & Immunology
Population Analysis
12/06/2025
Jessica Garlewicz
The findings of an analysis underscore the potential role of common viral infections as a trigger for AU and offer insight into changing disease patterns during the COVID-19 pandemic.
The findings of an analysis underscore the potential role of common viral infections as a trigger for AU and offer insight into changing disease patterns during the COVID-19 pandemic.
The findings of an analysis...
12/06/2025
Allergy & Immunology
Conference Coverage
11/14/2025
Rebecca Mashaw
A significant majority of obstetricians surveyed were interested in receiving additional education and guidelines to help them guide care of pregnant patients with allergies.
A significant majority of obstetricians surveyed were interested in receiving additional education and guidelines to help them guide care of pregnant patients with allergies.
A significant majority of...
11/14/2025
Allergy & Immunology
News
11/13/2025
Jessica Garlewicz
In a phase 2, randomized, double-blind trial, povorcitinib significantly reduced hives and itch severity in patients with chronic spontaneous urticaria refractory to second-generation H1-antihistamines.
In a phase 2, randomized, double-blind trial, povorcitinib significantly reduced hives and itch severity in patients with chronic spontaneous urticaria refractory to second-generation H1-antihistamines.
In a phase 2, randomized,...
11/13/2025
Allergy & Immunology